Keywords: ipsen/medicis, submit, reloxin, bla, fda, french, drugmaker

Ipsen/Medicis submit Reloxin BLA to FDA

Article | 24 March 2008

Print This

French drugmaker Ipsen has submitted a Biologics License Application to the US Food and Drug Administration for its esthetic-use botulinum ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in